PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Maquet Critical Care AB

USPTO PatentsView assignee record - 75 granted patents across 11 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).

Explore the portfolio See the ranking
75
Total patents granted
11
CPC technology areas
16.0
Avg claims per patent
+21%
5-year filing velocity

The verdict

Maquet holds 75 US patents across 11 technology areas, rank #4,676 of 50,000 tracked assignees.

#4,676
of 50,000 US assignees by volume
Top 36%
by Innovation Score (40.4/100)
16.0
avg claims per patent
+21%
filing velocity, last 5 yrs

Portfolio overview

Maquet Critical Care AB has been granted 75 US utility patents between 2015 and 2025, placing Maquet Critical Care AB at rank #4,676 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.0 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a Foreign Corporation, Maquet Critical Care AB is one of the more focused assignees in the PatentsView dataset. By volume, Maquet sits between Incept, Llc (75 patents, rank #4,672) and Phoenix Pioneer Technology Co., Ltd. (75 patents, rank #4,680) - the closest US assignees by grant volume. The composite Innovation Score of 40.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 41 grants, compared with 34 in the 2015–2019 window, a +21% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Maquet Critical Care AB's 16.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Maquet Critical Care AB against peers pursuing similar technology classes.

Who files at Maquet's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Maquet holds 75 patents at rank #4,676, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Maquet

By rank, the assignees closest to #4,676 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media INTO)

Other assignees with the most granted patents in Maquet's primary technology class.

Maquet's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

051015 2015201620182019202020212022202320242025 6
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Maquet Critical Care AB patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 13 17.3%
2016 11 14.7%
2018 3 4.0%
2019 7 9.3%
2020 10 13.3%
2021 9 12.0%
2022 7 9.3%
2023 5 6.7%
2024 4 5.3%
2025 6 8.0%

Which technologies does Maquet Critical Care AB patent most?

Top 11 of 11 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#4,676

Across all tracked assignees

Innovation Score

40.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Maquet Critical Care AB hold?
Maquet Critical Care AB holds 75 US granted patents filed between 2015 and 2025, spanning 11 technology areas.
What is Maquet Critical Care AB's Innovation Score?
Maquet Critical Care AB has an Innovation Score of 40.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Maquet Critical Care AB focus on?
Maquet Critical Care AB's top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 56 patents. The company has filed patents in 11 CPC subclasses total.
Is Maquet Critical Care AB's patent filing rate increasing or decreasing?
Maquet Critical Care AB's recent filing velocity is +21% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Maquet Critical Care AB's patents?
Maquet Critical Care AB's patents average 16.0 claims each. This falls within the standard range, providing solid legal coverage.
How is the Maquet Critical Care AB patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Maquet's 75 grants land it in the top 36% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Maquet ranks #4,676 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61M - see who else leads that technology area. A61M leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.